151 related articles for article (PubMed ID: 38329923)
1. Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance - United States, 2024.
Berry I; Rubis AB; Howie RL; Sharma S; Marasini D; Marjuki H; Crowe S; McNamara LA
MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(5):99-103. PubMed ID: 38329923
[TBL] [Abstract][Full Text] [Related]
2. Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.
Saito R; Nakajima J; Prah I; Morita M; Mahazu S; Ota Y; Kobayashi A; Tohda S; Kamiya H; Takahashi H; Ohnishi M
Microbiol Spectr; 2022 Jun; 10(3):e0062722. PubMed ID: 35467371
[TBL] [Abstract][Full Text] [Related]
3. Antibiotics for preventing meningococcal infections.
Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2006 Oct; (4):CD004785. PubMed ID: 17054214
[TBL] [Abstract][Full Text] [Related]
4. Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020.
McNamara LA; Potts C; Blain AE; Retchless AC; Reese N; Swint S; Lonsway D; Karlsson M; Lunquest K; Sweitzer JJ; Wang X; Hariri S; Fox LM;
MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(24):735-739. PubMed ID: 32555137
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics for preventing meningococcal infections.
Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
[TBL] [Abstract][Full Text] [Related]
6. Antibiotics for preventing meningococcal infections.
Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004785. PubMed ID: 24163051
[TBL] [Abstract][Full Text] [Related]
7. Antibiotics for preventing meningococcal infections.
Zalmanovici Trestioreanu A; Fraser A; Gafter-Gvili A; Paul M; Leibovici L
Cochrane Database Syst Rev; 2011 Aug; (8):CD004785. PubMed ID: 21833949
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
Potts CC; Rodriguez-Rivera LD; Retchless AC; Hu F; Marjuki H; Blain AE; McNamara LA; Wang X
J Infect Dis; 2022 Jun; 225(11):1871-1875. PubMed ID: 35266516
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
Willerton L; Lucidarme J; Walker A; Lekshmi A; Clark SA; Walsh L; Bai X; Lee-Jones L; Borrow R
PLoS One; 2021; 16(11):e0260677. PubMed ID: 34843604
[TBL] [Abstract][Full Text] [Related]
10. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
Kawasaki Y; Matsubara K; Takahashi H; Morita M; Ohnishi M; Hori M; Isome K; Iwata A; Nigami H; Ikemachi M; Yamamoto G; Ohkusu K
J Infect Chemother; 2018 Apr; 24(4):305-308. PubMed ID: 29233459
[TBL] [Abstract][Full Text] [Related]
11. In brief: Meningococcal prophylaxis.
Med Lett Drugs Ther; 2008 Apr; 50(1283):25. PubMed ID: 18391897
[No Abstract] [Full Text] [Related]
12. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
[TBL] [Abstract][Full Text] [Related]
13. β-Lactamase-Producing, Ciprofloxacin-Resistant Neisseria meningitidis Isolated From a 5-Month-Old Boy in the United States.
Taormina G; Campos J; Sweitzer J; Retchless AC; Lunquest K; McNamara LA; Reese N; Karlsson M; Hanisch B
J Pediatric Infect Dis Soc; 2021 Apr; 10(3):379-381. PubMed ID: 32743638
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of invasive Neisseria meningitidis strains isolated in Germany to azithromycin, an alternative agent for post-exposure prophylaxis.
Krone M; Lâm TT; Vogel U; Claus H
J Antimicrob Chemother; 2020 Apr; 75(4):984-987. PubMed ID: 31971241
[TBL] [Abstract][Full Text] [Related]
15. Emergence of resistance to ciprofloxacin in Neisseria meningitidis in Brazil.
Gorla MC; Cassiolato AP; Pinhata JMW; de Moraes C; Corso A; Gagetti P; Lemos AP
J Med Microbiol; 2018 Mar; 67(3):286-288. PubMed ID: 29458676
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup Y Neisseria meningitidis in the United States.
Potts CC; Retchless AC; McNamara LA; Marasini D; Reese N; Swint S; Hu F; Sharma S; Blain AE; Lonsway D; Karlsson M; Hariri S; Fox LM; Wang X;
Clin Infect Dis; 2021 Oct; 73(7):1185-1193. PubMed ID: 33900407
[TBL] [Abstract][Full Text] [Related]
17. Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(7):173-5. PubMed ID: 18288075
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Blondeau JM; Yaschuk Y
Antimicrob Agents Chemother; 1995 Nov; 39(11):2577-9. PubMed ID: 8585750
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Gorla MC; Pinhata JMW; Dias UJ; de Moraes C; Lemos AP
J Med Microbiol; 2018 Jun; 67(6):750-756. PubMed ID: 29717974
[TBL] [Abstract][Full Text] [Related]
20. Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village.
Shehab S; Keller N; Barkay A; Leitner L; Leventhal A; Block C
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):749-53. PubMed ID: 9923513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
